

HY-168519 · 50 mg
MedChemExpress · Cat: HY-168519
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/stat3-in-36.htmlDescription
STAT3-IN-36 compound 11g is a triple-target inhibitor targeting LRPPRC, STAT3, and CDK1 with anticancer activity. STAT3-IN-36 binds to LRPPRC, STAT3, and CDK1, exerting a stronger anticancer effect than TMF HY-N6818 or Capecitabine HY-B0016 . STAT3-IN-36 inhibits HGC27 cells with IC50 1.8 ?M..







